Aug 3, 2016, 16:06 PM by Michael Croft

Forbes | Biotech and pharmaceutical industry professionals are busy people like everyone else. But they still find time to read books, especially when schedules slow down a tad during summer. So what are biotech professionals reading, and recommending, these days?

Aug 3, 2016, 12:13 PM by Michael Croft

KANSAS CITY, KS, UNITED STATES - Aug 3, 2016 - Sekisui XenoTech has added additional hepatotoxicity screening assays and methodologies to the company’s existing cytotoxicity contract research services

Aug 3, 2016, 10:45 AM by Michael Croft

Bio-IT World Briefs | Editas Medicine and Massachusetts General Hospital (MGH) announced an exclusive licensing agreement this morning, under which Editas can access intellectual property and technology related to high-fidelity Cas9 nucleases and Cas9 PAM variants that will enable the company to address an expanded range of genetically-defined diseases with the potential for enhanced specificity.

Aug 3, 2016, 09:33 AM by Michael Croft

Nature News & Comment | Daniel Himmelstein built a free online network to meld data from 28 public sources on links between drugs, genes, and diseases. Then he spent months chasing legal permission to republish the online data sets.

Aug 3, 2016, 09:32 AM by Michael Croft

PITTSBURGH, PA - Aug 3, 2016 - Curable, a non-profit research accelerator that applies engineering approaches to medicine to develop solutions for rare diseases, today announced that its Chief Executive Officer Lisa Boyette, MD, PhD, has been named a 2016 PharmaVOICE 100 honoree

Aug 2, 2016, 16:00 PM by Michael Croft

WSJ | Biotechnology giant Biogen Inc. has drawn takeover interest from drug companies including Merck & Co. and Allergan PLC, raising the possibility of another huge deal in the health-care industry.

Aug 2, 2016, 10:13 AM by Michael Croft

MUNICH, GERMANY - Aug 2, 2016 - Definiens, the pioneer in Tissue Phenomics solutions for diagnostics development and commercialization, today announced the release of its Clinical Development Offering, making the company the premier provider of comprehensive tissue-based services from discovery to commercialization

Aug 2, 2016, 09:02 AM by Michael Croft

The New York Times | After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.

Aug 1, 2016, 22:21 PM by Michael Croft

STAT | Glaxo and Verily Life Sciences will invest $715 million in Galvani Bioelectronics and hope to win approval for their implantable devices in several years.

Aug 1, 2016, 15:40 PM by Michael Croft

Bio-IT World Briefs | News and product launches from bio IT, clinical IT, and diagnostics technologies include data management installation at Scripps Research Institute and new NGS panels for detection of extremely rare (low-frequency) mutations.

Jul 29, 2016, 12:07 PM by Michael Croft

Computerworld | An industry focus is one of the key factors IBM is betting will set it apart from cloud competitors including Google, Microsoft and Amazon Web Services, IBM's top cloud exec says.

Jul 29, 2016, 05:54 AM by Michael Croft

CAMBRIDGE, UK - Jul 29, 2016 - As the use of whole genome and exome analysis grows it is increasing the workload for the Genomic Medicine Centres

Jul 28, 2016, 15:46 PM by Michael Croft

GAITHERSBURG, MD - Jul 28, 2016 - The National Institute of Standards and Technology (NIST) has issued one of the world’s most intricate measurement standards: an exhaustively analyzed antibody protein that the biopharmaceutical industry will use to help ensure the quality of treatments across a widening range of health conditions, including cancers, autoimmune disorders and infectious diseases

Jul 28, 2016, 15:03 PM by Michael Croft

Forbes | BioMarin became one of the world's most valuable biotechs by jettisoning costly distractions and focusing on one thing: treating some of the rarest diseases on the planet.

Jul 28, 2016, 12:25 PM by Michael Croft

MIT Technology Review | Startups focused on Asia are among those aiming to bring precision medicine to far more people.

Jul 28, 2016, 10:32 AM by Michael Croft

Computerworld | Microsoft is creating some 3.2 million square feet of data center space in the West Des Moines, Iowa, area but in three separate locations. The combined investment is about $3.5 billion.

Jul 27, 2016, 23:32 PM by Michael Croft

SHIRLEY, NY - Jul 28, 2016 - Creative Biostructure is a provider of membrane protein products and services. At here, we provide a variety of technologies to meet the requirements of each customer

Jul 27, 2016, 10:11 AM by Michael Croft

Xconomy | After eight years at the helm of Eli Lilly, a tenure characterized by a steadfast belief in home-grown research, rather than deals, John Lechleiter is retiring. David Ricks, who currently runs Lilly's diversified bio-medicines unit-which develops drugs for neurological and cardiovascular disorders, among other diseases-will be named CEO on Jan. 1

Jul 27, 2016, 10:10 AM by Michael Croft

Nature News & Comment | Nature and the Nature journals are diversifying their presentation of performance indicators. Impact factor is crude and also misleading. It effectively undervalues papers in disciplines that are slow-burning or have lower characteristic citation rates. Accordingly, Nature has updated its online journal metrics page to include an array of additional bibliometric data.

Jul 27, 2016, 05:40 AM by Michael Croft

ALBANY, NY - Jul 27, 2016 - Bioelectronics is an emerging branch of medical science dealing with combined application of the principles of biology and electrical engineering